- Home
- GROW vs FGEN Comparison
GROW vs FGEN Comparison
Compare GROW & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- FGEN
- Stock Information
- Founded
- GROW 1968
- FGEN 1993
- Country
- GROW United States
- FGEN United States
- Employees
- GROW N/A
- FGEN N/A
- Industry
- GROW Investment Managers
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- FGEN Health Care
- Exchange
- GROW Nasdaq
- FGEN Nasdaq
- Market Cap
- GROW 31.8M
- FGEN 33.5M
- IPO Year
- GROW N/A
- FGEN 2014
- Fundamental
- Price
- GROW $2.43
- FGEN $7.26
- Analyst Decision
- GROW
- FGEN Strong Buy
- Analyst Count
- GROW 0
- FGEN 1
- Target Price
- GROW N/A
- FGEN $250.00
- AVG Volume (30 Days)
- GROW 38.8K
- FGEN 48.5K
- Earning Date
- GROW 09-09-2025
- FGEN 08-05-2025
- Dividend Yield
- GROW 3.66%
- FGEN N/A
- EPS Growth
- GROW N/A
- FGEN N/A
- EPS
- GROW 0.01
- FGEN N/A
- Revenue
- GROW $8,932,000.00
- FGEN $6,996,000.00
- Revenue This Year
- GROW N/A
- FGEN N/A
- Revenue Next Year
- GROW N/A
- FGEN N/A
- P/E Ratio
- GROW $233.35
- FGEN N/A
- Revenue Growth
- GROW N/A
- FGEN N/A
- 52 Week Low
- GROW $2.02
- FGEN $4.50
- 52 Week High
- GROW $2.69
- FGEN $33.49
- Technical
- Relative Strength Index (RSI)
- GROW 57.74
- FGEN 51.44
- Support Level
- GROW $2.43
- FGEN $7.04
- Resistance Level
- GROW $2.58
- FGEN $7.56
- Average True Range (ATR)
- GROW 0.06
- FGEN 0.55
- MACD
- GROW -0.00
- FGEN 0.03
- Stochastic Oscillator
- GROW 65.22
- FGEN 42.40
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.